scispace - formally typeset
T

Thomas J. Blacklock

Researcher at Novartis

Publications -  154
Citations -  3171

Thomas J. Blacklock is an academic researcher from Novartis. The author has contributed to research in topics: Catalysis & Enantioselective synthesis. The author has an hindex of 33, co-authored 154 publications receiving 3053 citations. Previous affiliations of Thomas J. Blacklock include Merck & Co..

Papers
More filters
Patent

Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor

TL;DR: In this paper, a specific combination, linked prodrug or a compound of an angiotensin receptor antagonist and a NEPi, is used in the treatment of hypertension.
Journal ArticleDOI

A Practical and Chemoselective Reduction of Nitroarenes to Anilines Using Activated Iron

TL;DR: In this paper, the reduction of nitroarenes to anilines using activated iron generated by Fe/HCl or Zn/FeSO 4 was described, and a variety of functional groups such as alkyne, ketone, enone, nitrile, lactone, and aromatic halide were well tolerated under these conditions.
Journal ArticleDOI

LCZ696: a dual-acting sodium supramolecular complex

TL;DR: LCZ696 is the first example of a dual-acting pharmaceutical built as a supramolecular complex delivering two pharmacologic effects—angiotensin receptor 1 (AT1) blockage and neprilysin (NEP) inhibition.